Belpointe Asset Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Belpointe Asset Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$992	–	3695
2023 Q1	$992	Buy	+100	New	+$991	﹤0.01%	3480

Belpointe Asset Management's APEN Position: Q2 2023 in Review

Belpointe Asset Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 100 shares — an estimated $992 sold.

Belpointe Asset Management first reported a position in APEN in Q1 2023 and held it in 1 quarter. The position peaked at $992 in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Belpointe Asset Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Belpointe Asset Management sold 100 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $992.
Belpointe Asset Management first reported a position in Apollo Endosurgery, Inc. in Q1 2023 and held it in 1 quarter.
Belpointe Asset Management's Apollo Endosurgery, Inc. position peaked at $992 in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.